| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 263.210 | 289.352 | 329.825 | 335.468 | 306.521 | 308.961 | 299.852 | 329.819 | 324.926 | 327.302 |
| Total Income - EUR | 267.009 | 290.739 | 331.533 | 338.545 | 306.891 | 309.171 | 299.994 | 329.830 | 324.928 | 327.328 |
| Total Expenses - EUR | 271.362 | 301.002 | 344.263 | 351.770 | 349.294 | 300.617 | 279.398 | 310.152 | 316.746 | 316.639 |
| Gross Profit/Loss - EUR | -4.353 | -10.263 | -12.730 | -13.225 | -42.403 | 8.554 | 20.596 | 19.678 | 8.181 | 10.689 |
| Net Profit/Loss - EUR | -5.199 | -10.263 | -16.298 | -16.611 | -45.472 | 5.793 | 17.549 | 16.301 | 4.932 | 6.368 |
| Employees | 6 | 7 | 7 | 7 | 7 | 6 | 6 | 6 | 6 | 6 |
Check the financial reports for the company - Chamomilla Pharm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 16.149 | 9.788 | 6.120 | 2.273 | 138 | 290 | 0 | 1.877 | 1.445 | 1.889 |
| Current Assets | 97.465 | 89.680 | 110.929 | 107.931 | 62.775 | 79.330 | 85.557 | 83.754 | 82.666 | 95.179 |
| Inventories | 55.499 | 62.561 | 67.856 | 60.930 | 30.432 | 39.822 | 49.991 | 48.399 | 50.335 | 55.412 |
| Receivables | 35.383 | 24.191 | 42.434 | 46.235 | 32.019 | 36.984 | 33.602 | 32.697 | 30.780 | 31.355 |
| Cash | 6.583 | 2.927 | 639 | 766 | 324 | 2.524 | 1.963 | 2.659 | 1.552 | 8.411 |
| Shareholders Funds | 45.065 | 34.919 | 18.030 | 1.088 | -44.405 | -37.770 | -23.808 | -17.686 | -12.700 | -6.262 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 69.203 | 64.819 | 99.284 | 109.376 | 107.574 | 117.641 | 109.610 | 104.243 | 97.735 | 117.814 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Chamomilla Pharm Srl